[1]
Shahid Ullah et al. 2024. STRUCTURE-BASED VIRTUAL SCREENING STUDY OF FDA‑APPROVED DRUGS TO INHIBIT TP53 72 ARG/PRO VARIANT IDENTIFIED IN ACUTE LYMPHOCYTIC PATIENT VIA WHOLE EXOME SEQUENCING. Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), 2304–2415. DOI:https://doi.org/10.53555/jptcp.v31i3.5046.